Ulf Tomas Fristedt

Title: The Innovative Contributions of Ulf Tomas Fristedt

Introduction

Ulf Tomas Fristedt, a noted inventor based in Helsingborg, Sweden, has made significant contributions to the field of pharmaceuticals. His inventive spirit and dedication to research have led to the development of a unique compound that holds promise in drug formulation.

Latest Patents

Fristedt is the holder of a patent for the compound N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, along with its preparation and uses. This patent outlines a pharmaceutical composition that contains laquinimod or its pharmaceutically acceptable salts, combined with his novel compound or its salts. This innovative formulation aims to enhance therapeutic options for various medical conditions.

Career Highlights

Ulf Tomas Fristedt currently works for Teva Pharmaceutical Industries Limited, a global leader in generic and specialty medicines. His career at Teva has been marked by a commitment to advancing medical science and developing effective therapeutic solutions.

Collaborations

During his tenure, Fristedt has had the opportunity to collaborate with notable colleagues, including Vladimir Ioffe and Konstantin Ulanenko. These collaborations have spurred innovative research and bolstered the development of new pharmaceutical compositions, contributing to the broader scientific community.

Conclusion

In conclusion, Ulf Tomas Fristedt's work in pharmaceutical innovation illustrates the impact of dedicated inventors on healthcare advancements. With his patent and professional collaborations, he continues to contribute valuable insights and formulations that benefit the medical field and patients alike.